Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-03-03 @ 2:21 AM
Study NCT ID:
NCT01370005
Status:
COMPLETED
Last Update Posted:
2016-02-22
First Post:
2011-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-08
First Submit QC Date:
None
Study First Post Date:
2011-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-16
Results First Submit QC Date:
None
Results First Post Date:
2014-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-22
Last Update Post Date:
2016-02-22
Last Update Post Date Type:
ESTIMATED